As shown in Fig. 3C,D, NOTCH1 blockade can significantly decrease the CSC percentage of CD4+ CD133+ (P < 0.01) and CD44+ cells (P < 0.05) in HNSCC, whereas no statistical significance was observed for CD133+ cells. This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.